ABCD audit of FreeStyle Libre device for flash glucose monitoring shows improved diabetes control in Type 1 diabetes and fewer hospital admissions
A national UK audit of the first technology device allowed to be prescribed for people with Type 1 Diabetes, presented at the American Diabetes Association in San Francisco, shows important benefits both in lowering glucose levels in those with high levels before use of the device and a reduction of hypoglycaemic attacks (‘hypos’ caused by low blood glucose levels). There is also a reduction in the rate of diabetes related-hospital admissions and a reduction of diabetes-related psychological distress during the initial six months of FreeStyle Libre use.